Levels of growth differentiation factor-15 are high and correlate with clinical severity in transfusion-independent patients with β thalassemia intermedia.

[1]  Khaled M Musallam,et al.  Optimal management of β thalassaemia intermedia , 2011, British journal of haematology.

[2]  A. Taher,et al.  Bone disease and skeletal complications in patients with β thalassemia major. , 2011, Bone.

[3]  J. Wansapura,et al.  High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension. , 2010, Blood.

[4]  M. Cappellini,et al.  Age‐related complications in treatment‐naïve patients with thalassaemia intermedia , 2010, British journal of haematology.

[5]  M. Cappellini,et al.  Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. , 2010, Blood.

[6]  Jeffery L. Miller,et al.  Growth differentiation factor 15 in erythroid health and disease , 2010, Current opinion in hematology.

[7]  M. Cappellini,et al.  Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies , 2009, British journal of haematology.

[8]  M. Cappellini,et al.  Levels of non‐transferrin‐bound iron as an index of iron overload in patients with thalassaemia intermedia , 2009, British journal of haematology.

[9]  D. Weatherall,et al.  Disorders of Hemoglobin: THE MOLECULAR, CELLULAR, AND GENETIC BASIS OF HEMOGLOBIN DISORDERS , 2009 .

[10]  M. Cappellini,et al.  Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia , 2008, Haematologica.

[11]  S. Goh,et al.  High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin , 2007, Nature Medicine.

[12]  T. Ganz,et al.  Liver iron concentrations and urinary hepcidin in beta-thalassemia. , 2007, Haematologica.

[13]  John C Wood,et al.  Magnetic resonance imaging measurement of iron overload , 2007, Current opinion in hematology.

[14]  M. Cappellini,et al.  Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran , 2006, Thrombosis and Haemostasis.

[15]  M. Cappellini,et al.  Thalassemia intermedia: revisited. , 2006, Blood cells, molecules & diseases.

[16]  T. Coates,et al.  MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. , 2005, Blood.

[17]  T. S. St. Pierre,et al.  Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. , 2005, Blood.

[18]  A. Eldor,et al.  The hypercoagulable state in thalassemia. , 2002, Blood.